ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

PAMELA HOPE MD

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,615Medicare Part D Prescriptions Filled, Including Refills

Rank: 61 out of 315

$374K Total Retail Price of All Prescriptions

Rank: 117 out of 315

231 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
83% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Hawaii
Lower avg

Schedule Two
Controlled Substances

25% of this provider’s 231 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

19% of this provider’s 231 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

1% of this provider’s 7,408 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Hawaii
MIRTAZAPINE 462 461 1 68
METOPROLOL TARTRATE 375 374 2 18
LISINOPRIL 320 305 3 3
AMLODIPINE BESYLATE 264 261 4 2
CITALOPRAM HBR 255 255 5 72
LOSARTAN POTASSIUM 193 193 6 4
LEVOTHYROXINE SODIUM 172 160 7 6
OMEPRAZOLE 168 168 8 9
FUROSEMIDE 167 155 9 15
DONEPEZIL HCL 164 164 10 28
HYDROCODONE-ACETAMINOPHEN 133 130 S3 11 19
PEN NEEDLE 121 121 12 91
RISPERIDONE 118 118 13 148
LACTULOSE 112 112 14 115
ALENDRONATE SODIUM 109 109 15 12
PANTOPRAZOLE SODIUM 93 93 16 35
MORPHINE SULFATE 92 91 S2 17 235
HYDRALAZINE HCL 91 91 18 98
STROMECTOL 90 89 10 19 270
PREDNISONE 87 87 20 41
TAMIFLU 86 85 21 276
GLIPIZIDE 85 85 22 30
MORPHINE SULFATE ER 81 81 S2 23 128
CEFTRIAXONE 76 75 24 284
ATENOLOL 75 63 25 11
ZOLPIDEM TARTRATE 75 75 25 29
POLYETHYLENE GLYCOL 3350 72 61 27 106
HUMULIN 70-30 70 70 28 291
WARFARIN SODIUM 67 51 29 20
TRAZODONE HCL 65 65 30 93
NAMENDA 65 65 30 38
CLOPIDOGREL 64 64 32 25
LIDOCAINE HCL 61 60 33 305
AGGRENOX 60 48 34 308
TAMSULOSIN HCL 59 59 35 21
IPRATROPIUM-ALBUTEROL 57 57 36 255
CIPROFLOXACIN HCL 56 54 37 58
PAROXETINE HCL 56 56 37 142
CARBIDOPA-LEVODOPA 56 56 37 136
FINASTERIDE 55 55 40 60
MUPIROCIN 53 53 41 110
POTASSIUM CHLORIDE 52 52 42 36
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 24, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.